Company Profile for Corixa Corporation.Corixa is a developer of immunotherapeutics with a commitment to treating and preventing cancer and infectious diseases infectious diseases: see communicable diseases. by understanding and directing the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. . On June 30, 2003, Corixa announced that the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved BEXXAR for the treatment of patients with CD20 positive, follicular fol·lic·u·lar adj. 1. Relating to, having, or resembling a follicle or follicles. 2. Affecting or growing out of a follicle or follicles. , NHL NHL Non-Hodgkin's lymphoma, see there , with and without transformation, whose disease is refractory refractory Material that is not deformed or damaged by high temperatures, used to make crucibles, incinerators, insulation, and furnaces, particularly metallurgical furnaces. to Rituximab and has relapsed following chemotherapy. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. In addition to BEXXAR, Corixa currently has multiple programs in clinical development, including several product candidates that have advanced to and through late stage clinical trials. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are Powered by Corixa(tm) technology with the goal of making its potential products available to patients around the world. Corixa was founded in 1994 and is headquartered in Seattle, with additional operations in Hamilton, Mont., and South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. . For more information, please visit Corixa's Web site at http://www.corixa.com.
Company: Corixa Corporation
Headquarters Address: 1900 9th Avenue
Suite 1100
Seattle, WA 98101
Main Telephone: 206-366-3700
Website: www.corixa.com
Ticker: (Nasdaq:CRXA)
Type of Organization: Public
Industry: Health: Biotechnology
Key Executives: CEO: Steven Gillis
CFO: Michelle Burris
COO: David Fanning
Public Relations
Contact: Wendy Carhart
Phone: 503-443-7000
Email: wendyc@wagged.com
Investor Relations
Contact: Jim DeNike
Phone: 206-366-3720
Email: jim.denike@corixa.com
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion